Vertex Pharmaceuticals Inc. (VRTX-Q)

Their anti-pain drug is not addictive and it works. He's a believer.

Negative free cash flow to enter 2024, but it's turning positive. Shares are up 21% this year.

Even at this all time high don't sell. They're working on non-addictive painkillers

It's doing well, hitting new highs today. It's further along in its life cycle. Has a fine cystic fibrosis franchise. Shares are strong momentum, so he's staying in.

This drugmaker has a lock on MS and have new shots on pain management and other maladies. Lots going on. Up sharply this month.

Likes it for its CF franchise.

Likes it, but she trimmed it because a lot of the good news from its pain medicine is now in the stock.

PPH, an ETF for pharma producers, is breaking out and near a record. VTX and Eli Lilly are leaders in this space and Vertex has a great product for Cystic Fibrosis therapeutics. It is growing well and not too expensive.

They're in the MS business, so will they expand beyond MS? HE's confident they will and have some hit drugs.

A high-quality biopharma with a strong cystic fibrosis drug. Are trying to get into other franchises like diabetes treatments. Will do well long-run. Trades at 23x with 11% earnings growth, so you can take some profits now. Had a good run, so take some money off the table.

Not too expensive. They report next week. They have good momentum and products.